Detalhe da pesquisa
1.
p53 is associated with high-risk and pinpoints TP53 missense mutations in mantle cell lymphoma.
Br J Haematol
; 191(5): 796-805, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32748433
2.
TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy.
Blood
; 130(17): 1903-1910, 2017 10 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-28819011
3.
Bortezomib prevents cytarabine resistance in MCL, which is characterized by down-regulation of dCK and up-regulation of SPIB resulting in high NF-κB activity.
BMC Cancer
; 18(1): 466, 2018 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29695239
4.
Ibrutinib inhibits antibody dependent cellular cytotoxicity induced by rituximab or obinutuzumab in MCL cell lines, not overcome by addition of lenalidomide.
Exp Hematol Oncol
; 8: 16, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31406628
5.
Frequency and clinical implications of SOX11 expression in Burkitt lymphoma.
Leuk Lymphoma
; 58(7): 1760-1763, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27869516